Eagle Pharmaceuticals to Present at the William Blair 42nd Annual Growth Stock Conference
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) announced that its CEO, Scott Tarriff, and CFO, Brian Cahill, will present at the William Blair 42nd Annual Growth Stock Conference on June 9, 2022, at 9:40 AM ET. The conference highlights Eagle's commitment to developing innovative medicines aimed at improving patient outcomes. The company’s portfolio includes products like vasopressin injection and BENDEKA, along with a strong pipeline in oncology and CNS/metabolic critical care. For more details, visit Eagle's website.
- None.
- None.
WOODCLIFF LAKE, N.J., May 26, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”) today announced that Scott Tarriff, President and Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the William Blair 42nd Annual Growth Stock Conference as follows:
Date: | Thursday, June 9, 2022 |
Time: | 9:40AM ET/8:40AM CT |
Webcast: | Click Here |
About Eagle Pharmaceuticals, Inc.
Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include vasopressin injection, PEMFEXY™, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM (Japan), and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.
Investor Relations for Eagle Pharmaceuticals, Inc.:
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
FAQ
When will Eagle Pharmaceuticals present at the William Blair Conference?
What time is the Eagle Pharmaceuticals' presentation at the conference?
Who will represent Eagle Pharmaceuticals at the William Blair Conference?
Where can I watch the Eagle Pharmaceuticals conference presentation?